Our Mission

SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

Early detection at point of care

Nevisense

The Nevisense platform uses advanced technology powerd by AI to empower healthcare professionals by facilitating improved diagnostic accuracy, enabled disease monitoring, and  early detection of melanoma at the most curable stage. Its a non-invasive measurement that provides phycisians with objective and actionable data at point-of-care.

Read more

News

Events

Our unique platform

Nevisense

The unique Nevisense platform utilizes advanced EIS- technology combined with AI to empower healthcare professionals by improving diagnostic accuracy, enabling disease monitoring, and facilitating early detection of skin cancer. The Nevisense procedure is non-invasive and provides clinicians with objective and actionable data, at point-of-care. It has been developed based on 20+ years of research from the Karolinska Institute and several years of clinical experience.

Read more

Lorem ipsum dolor

Lorem ipsum dolor

Integer venenatis sem in orci volutpat, eget placerat est mattis. Vivamus rhoncus leo sed nulla aliquam, id suscipit libero sagittis. Aenean vitae condimentum nisi, ac hendrerit libero.

Read more